Senerth, E, Whaley, P, Akl, E, Beverly, B, Alonso-Coello, P, Rooney, A, Schünemann, HJ, Thayer, KA, Tsaioun, K, Morgan, RL. GRADE guidance 40: The GRADE evidence-to-decision framework for environmental and occupational health. ENVIRONMENT INTERNATIONAL. 2025; 197DOI:10.1016/j.envint.2025.109314. PMID:39965475. IF:9.700(Q1/1D).

Morgano GP, Wiercioch W, Piovani D, Neumann I, Nieuwlaat R, Piggott T, Alonso-Coello P, Mbuagbaw L, Rigoni M, Bognanni A, Celedon N, Mustafa RA, Pottie K, Leontiadis GI, Akl EA, Bonovas S, Schünemann HJ. Defining decision thresholds for judgments on health benefits and harms using the grading of recommendations assessment, development, and evaluation (GRADE) evidence to decision (EtD) frameworks: a randomized methodological study (GRADE-THRESHOLD). JOURNAL OF CLINICAL EPIDEMIOLOGY. 2025; 179DOI:10.1016/j.jclinepi.2024.111639. PMID:39662641. IF:5.200(Q1/1D).

Sousa-Pinto, B, Marques-Cruz, M, Neumann, I, Chi, Y, Nowak, AJ, Reinap, M, Awad, M, Nothacker, M, Trucl, M, Brozek, J, Alonso-Coello, P, Wiercioch, W, Qaseem, A, Akl, EA, Schünemann, HJ. Guidelines International Network: Principles for Use of Artificial Intelligence in the Health Guideline Enterprise. ANNALS OF INTERNAL MEDICINE. 2025; 178(3)DOI:10.7326/ANNALS-24-02338. PMID:39869912. IF:15.200(Q1/1D).

Roquer, M, Clotas, C, Bartroli, M. Online Gambling and At-Risk Gambling Behaviour in a Cross-Sectional Survey Among 13-19 Year-Old Adolescents in Barcelona. JOURNAL OF GAMBLING STUDIES. 2025; 41(1)DOI:10.1007/s10899-024-10341-3. PMID:39107565. IF:2.200(Q2/4D).

Tigova, O, Stival, C, Castellano, Y, Lugo, A, Fu, MRL, López, AM, Martínez, C, Soriano, JB, O'Donnell, R, Semple, S, López, MJ, Fernández, E, Gallus, S. Prevalence and determinants of smoke-free homes in 12 European countries: the TackSHS Survey. Erj Open Research. 2025; 11(2)DOI:10.1183/23120541.00950-2024. PMID:40129551. IF:4.000(Q1/2D).

Orozco, FV, Tabernero, D, Barbaglia, MG, Treviño, L, Trujillo, B, Marco, A, Carrillo, MA, Salinas, GR, Roca, FXM, Farran, JC, Buti, M, Pumarola-Sunyer, T, Rodriguez-Frias, F, Rando-Segura, A. Improving HCV Screening in Addiction Care Centers with Plasma Separation Cards. Pathogens. 2025; 14(3)DOI:10.3390/pathogens14030239. PMID:40137724. IF:3.300(Q2/5D).

Iruela, A, Moral, I, Gálvez, G, Jimenez, LM, Manzanera, R. Patient's experience as a tool in analyzing primary care in Catalonia. Journal Of Healthcare Quality Research. 2025; 40(2)DOI:10.1016/j.jhqr.2024.10.002. PMID:39547860. IF:(Q/D).

López-Chicón, P, Martínez, JIR, Castells-Sala, C, Lopez-Puerto, L, Ruiz-Ponsell, L, Fariñas, O, Vilarrodona, A. Pericardium decellularization in a one-day, two-step protocol. MOLECULAR AND CELLULAR BIOCHEMISTRY. 2025; 480(3)DOI:10.1007/s11010-024-05086-x. PMID:39251464. IF:3.700(Q2/5D).

Dalmases, M, Sánchez-de-la-Torre, M, Martinez, D, Minguez, O, Vaca, R, Pascual, L, Aguilá, M, Gracia-Lavedan, E, Benitez, ID, Pinilla, L, Cortijo, A, Gort-Paniello, C, Claret, RB, Martinez-Garcia, MA, Mediano, O, Peralta, SR, Fortuna-Gutierrez, AM, Marquez, PP, Drager, LF, Cabrini, M, Masa, JF, Penafiel, JC, Vázquez, S, Abad, J, García-Rio, F, Casitas, R, Lee, CH, Barbé, F, Torres, G. The Effect of Obstructive Sleep Apnea on Subclinical Target Organ Damage in Patients With Resistant Hypertension. ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(3)DOI:10.1016/j.arbres.2024.07.018. PMID:39277516. IF:9.200(Q1/1D).

Webster, A, Fog, LS, Hall, E, van Rossum, PSN, Nevens, D, Montay-Gruel, P, Franco, P, Joyce, E, Jornet, N, Clark, CH, Bertholet, J. ESTRO guidelines for developing questionnaires in survey-based radiation oncology research. Clinical and Translational Radiation Oncology. 2025; 51DOI:10.1016/j.ctro.2024.100895. PMID:39898327. IF:2.700(Q2/4D).

Esmel-Vilomara, R, Riaza, L, Costa-Comellas, L, Sabaté-Rotes, A, Gran, F. Asymmetric Myocardial Involvement as an Early Indicator of Cardiac Dysfunction in Pediatric Dystrophinopathies: A Study on Cardiac Magnetic Resonance (CMR) Parametric Mappings. PEDIATRIC CARDIOLOGY. 2025; 46(3)DOI:10.1007/s00246-024-03488-8. PMID:38687374. IF:1.400(Q3/6D).

Puig, N, Camps-Renom, P, Garcia, E, Benítez-Amaro, A, Aguilera-Simón, A, Fernández-León, A, Quesada, JLS, Llorente-Cortés, V, Benitez, S. sICAM-1 concentrations are associated with inflammation in contralateral carotid plaque in patients with ischemic stroke. Clinica E Investigacion En Arteriosclerosis. 2025; 37(2)DOI:10.1016/j.arteri.2024.07.002. PMID:39095307. IF:(Q/D).

Flotats, A. Cardiac denervation and morpho-functional changes, two sides of the same coin in wild-type transthyretin amyloid cardiomyopathy?. JOURNAL OF NUCLEAR CARDIOLOGY. 2025; 45DOI:10.1016/j.nuclcard.2025.102145. PMID:39870299. IF:2.700(Q2/4D).

Lobo-Prat, D, Sainz, L, Laiz, A, De Dios, A, Fontcuberta, L, Fernández, S, Masip, M, Riera, P, Pages-Puigdemont, N, Ros, S, Gomis-Pastor, M, Corominas, H. Designing an integrated care pathway for spondyloarthritis: A Lean Thinking approach. JOURNAL OF EVALUATION IN CLINICAL PRACTICE. 2025; 31(2)DOI:10.1111/jep.14132. PMID:39253893. IF:2.100(Q2/3D).

Redondo, S, Costa, M, Moreno-Martinez, ME, Arguello-Tomas, M, Riba, M, Aso, O, Iranzo, E, Esquirol, A, Sierra, J, Briones, J, Martino, R, Zapico, E, Garcia-Cadenas, I. Development and Clinical Validation of Liquid Chromatography-Tandem Mass Spectrometry for Measuring Ruxolitinib in Steroid-Refractory Graft-Versus-Host Disease: A First Step Towards Optimized Treatment. EUROPEAN JOURNAL OF HAEMATOLOGY. 2025; 114(3)DOI:10.1111/ejh.14349. PMID:39545520. IF:2.300(Q2/5D).

Puig L., Daudén E., Cuervas-Mons M., Novella C., Guisado C.. Persistence and effectiveness of guselkumab treatment in patients with moderate-to-severe plaque psoriasis in a non-interventional real-world setting: The SPRING study. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2025; 39DOI:10.1111/jdv.19403. PMID:37567861. IF:8.000(Q1/1D).

Kokolakis, G, Guillem, P, Vilarrasa, E, Alarcon, I, Go, M, Newbold, G, Mamareli, A, Richardson, C, McGrath, B, Kirby, JS. The impact on pain and mental health in patients with hidradenitis suppurativa: Results from the HS Uncovered global patient survey. EXPERIMENTAL DERMATOLOGY. 2025; 34DOI:. PMID:. IF:3.100(Q2/3D).

Garbayo-Salmons, P, Vilarrasa, E, Haselgruber, S, Gamissans, M, Ciudad, C, Martorell, A, Aguayo-Ortiz, RS, Romani, J, Fornons-Servent, R, Molina-Leyva, A. Lymphedema in hidradenitis suppurativa: A multicenter case series. EXPERIMENTAL DERMATOLOGY. 2025; 34DOI:. PMID:. IF:3.100(Q2/3D).

Vilarrasa, E, Salmons, PG, Bassas-Vila, J, Mora, V, Fuertes, I, Luque, M, Fornons-Servent, R, Martin, G, Aguayo-Ortiz, RS, Ceravalls, J, Mollet, J, Gómez, A, Masferrer, E, Corral, O, Matas, C, Romaní, J. Major predictors of remission in hidradenitis suppurativa: An 8-year survival study with adalimumab. EXPERIMENTAL DERMATOLOGY. 2025; 34DOI:. PMID:. IF:3.100(Q2/3D).

Silverberg, JI, Bieber, T, Paller, AS, Beck, L, Kamata, M, Puig, L, Wiseman, M, Ezzedine, K, Irvine, AD, Foley, P, Del Rosso, J, Gold, LS, Johansson, E, Dossenbach, M, Gallo, G, Akmaz, B, Casillas, M, Karlsson, A, Curteis, T, Chovatiya, R. Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of Efficacy. Dermatology and Therapy. 2025; 15(3)DOI:10.1007/s13555-025-01357-7. PMID:39953372. IF:4.200(Q1/1D).